Recent Material Events - Vanda Pharmaceuticals, Inc (VNDA)

Filing Date	Description
2008-08-05	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-07-28	Exhibit No. Description 99.1 Press Release of Vanda Pharmaceuticals Inc. dated July 28, 2008. ...
2008-06-26	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-06-05	Press Release of Laboratory Corporation of America® Holdings and Vanda Pharmaceuticals Inc. dated June 5, 2008. ...
2008-05-07	Vanda Pharmaceuticals Inc. (the “Company”) made presentations regarding the Company’s two late-stage product candidates, Fanapta TM and tasimelteon, as well as certain of the Company’s ongoing and planned commercialization and dev ...
2008-05-01	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-04-01	The Company intends to make presentations to certain investors regarding the Company’s operations, financial condition and prospects. The slides that will be used for such presentations are furnished as Exhibit 99.1 to this Form 8-K. ...
2008-02-14	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-12-13	On December 12, 2007, Vanda Pharmaceuticals Inc. issued a press release disclosing certain Phase III efficacy data from its New Drug Application for iloperidone. The full text of this press release is furnished as Exhibit 99.1 to this Current Rep ...
2007-11-08	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...